PHILIPPINE STAR/MICHAEL VARCAS
As part of a science-driven industry, the biopharmaceutical industry is leading the way in developing treatments, vaccines, and diagnostics for coronavirus disease 2019 (COVID-19). Our scientists are searching for potentially useful assets that can help with the development of new or repurposed treatments or vaccines to fight against the novel coronavirus. We are leveraging our manufacturing technologies to allow the rapid upscaling of production once a medicine or vaccine candidate is identified to meet the needs of the most affected populations. Phase 3 clinical trials are being conducted to establish safety and efficacy. We are collaborating with governments, global health and research organizations, and pharmaceutical laboratories to share knowledge, libraries, and technologies.